SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT001425P0018
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $498,438
- Period of performance
- Dec 4, 2024 – Dec 4, 2025
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- PSC 6550
- Place of performance
- MD
Public award description
SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.